Friday, May 9, 2014
Vibram withdraw health claims
Vibram makers of FiveFingers barefoot running shoes have agreed to a $3.75m (£2.2m) class-action settlement. The action was filed in 2012 by Vibram customers at odds’ with being misled by claims over the health benefits of the shoes. In a study of barefoot running shoes published in 2013 researchers found runners given Vibram's shoes were at greater risk of injury. The Vibram group had a significantly greater incidence of bone marrow edema after the training period, while neither group showed any soft tissue changes. The study found, and advised those wishing to transition to barefoot running to do so gradually. Vibram expressly denied and continues to deny any wrongdoing alleged in the Actions, and neither admits nor concedes any actual or potential fault, wrongdoing or liability. They have however as part of the settlement has agreed to remove claims that the shoes are effective in strengthening muscles or reducing injury. The settlement agreement is subject to court approval.